63 related articles for article (PubMed ID: 18370958)
1. Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions.
Cooper WA; Kohonen-Corish MR; Chan C; Kwun SY; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2008 Apr; 52(5):613-22. PubMed ID: 18370958
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations and patient-reported quality of life among patients with lung cancer.
Sloan JA; de Andrade M; Decker P; Wampfler J; Oswold C; Clark M; Yang P
J Clin Oncol; 2012 May; 30(14):1699-704. PubMed ID: 22454423
[TBL] [Abstract][Full Text] [Related]
3. Study of hesperetin effect on modulating transcription levels of MLH1 and MSH2 genes in SKBR3 breast cancer cell line.
Saleh NH; Al-Khafaji ASK; Babaei E
J Adv Pharm Technol Res; 2023; 14(4):338-344. PubMed ID: 38107455
[TBL] [Abstract][Full Text] [Related]
4. Retraction Note: Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38696002
[No Abstract] [Full Text] [Related]
5. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
Lo YL; Hsiao CF; Jou YS; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hsieh WS; Chen CJ; Hsiung CA
Lung Cancer; 2011 Jun; 72(3):280-6. PubMed ID: 21093954
[TBL] [Abstract][Full Text] [Related]
6. Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
Xie KJ; He HE; Sun AJ; Liu XB; Sun LP; Dong XJ
Asian Pac J Cancer Prev; 2014; 15(6):2591-6. PubMed ID: 24761869
[TBL] [Abstract][Full Text] [Related]
7. Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance.
Kouso H; Yoshino I; Miura N; Takenaka T; Ohba T; Yohena T; Osoegawa A; Shoji F; Maehara Y
J Surg Oncol; 2008 Oct; 98(5):377-83. PubMed ID: 18646042
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
[TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer.
Burgess JT; Rose M; Boucher D; Plowman J; Molloy C; Fisher M; O'Leary C; Richard DJ; O'Byrne KJ; Bolderson E
Front Oncol; 2020; 10():1256. PubMed ID: 32850380
[TBL] [Abstract][Full Text] [Related]
10. Joint Transcriptomic Analysis of Lung Cancer and Other Lung Diseases.
Otálora-Otálora BA; Florez M; López-Kleine L; Canas Arboleda A; Grajales Urrego DM; Rojas A
Front Genet; 2019; 10():1260. PubMed ID: 31867044
[No Abstract] [Full Text] [Related]
11. Clinical value of MLH1-negative circulating tumor cells in lung cancer patients.
Liang JY; Yang QF; Zeng YL; Liu YY; Liu YT; Gu FF; Hu Y; Zhang K; Zhong H; Liu L
Medicine (Baltimore); 2019 Jun; 98(25):e15721. PubMed ID: 31232917
[TBL] [Abstract][Full Text] [Related]
12. DNA repair pathways and cisplatin resistance: an intimate relationship.
Rocha CRR; Silva MM; Quinet A; Cabral-Neto JB; Menck CFM
Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e478s. PubMed ID: 30208165
[TBL] [Abstract][Full Text] [Related]
13. Small suitability of the DLEC1, MLH1 and TUSC4 mRNA expression analysis as potential prognostic or differentiating markers for NSCLC patients in the Polish population.
Kordiak J; Czarnecka KH; Pastuszak-Lewandoska D; Antczak A; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz J; Brzeziańska-Lasota E
J Genet; 2017 Jun; 96(2):227-234. PubMed ID: 28674222
[TBL] [Abstract][Full Text] [Related]
14. MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial.
Levallet G; Dubois F; Fouret P; Antoine M; Brosseau S; Bergot E; Beau-Faller M; Gounant V; Brambilla E; Debieuvre D; Molinier O; Galateau-Sallé F; Mazieres J; Quoix E; Pujol JL; Moro-Sibilot D; Langlais A; Morin F; Westeel V; Zalcman G
Oncotarget; 2017 Jan; 8(3):4313-4329. PubMed ID: 28008145
[TBL] [Abstract][Full Text] [Related]
15. Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.
Selinger CI; Li BT; Pavlakis N; Links M; Gill AJ; Lee A; Clarke S; Tran TN; Lum T; Yip PY; Horvath L; Yu B; Kohonen-Corish MR; O'Toole SA; Cooper WA
Histopathology; 2017 Feb; 70(3):402-411. PubMed ID: 27599111
[TBL] [Abstract][Full Text] [Related]
16. Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.
Walter RF; Mairinger FD; Werner R; Vollbrecht C; Hager T; Schmid KW; Wohlschlaeger J; Christoph DC
Oncotarget; 2016 Apr; 7(15):20166-79. PubMed ID: 27064343
[TBL] [Abstract][Full Text] [Related]
17. DNA mismatch repair deficiency accelerates lung neoplasm development in K-ras(LA1/+) mice: a brief report.
Downey CM; Jirik FR
Cancer Med; 2015 Jun; 4(6):897-902. PubMed ID: 25773971
[TBL] [Abstract][Full Text] [Related]
18. Expression of DNA-repair proteins and their significance in pancreatic cancer and non-cancerous pancreatic tissues of Sprague-Dawley rats.
Tan XG; Yang ZL; Yang LP; Miao XY
World J Surg Oncol; 2014 Feb; 12():32. PubMed ID: 24502441
[TBL] [Abstract][Full Text] [Related]
19. Low expression of MSH2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma.
Pereira CS; Oliveira MV; Barros LO; Bandeira GA; Santos SH; Basile JR; Guimarães AL; De Paula AM
J Appl Oral Sci; 2013; 21(5):416-21. PubMed ID: 24212987
[TBL] [Abstract][Full Text] [Related]
20. The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.
Postel-Vinay S; Vanhecke E; Olaussen KA; Lord CJ; Ashworth A; Soria JC
Nat Rev Clin Oncol; 2012 Feb; 9(3):144-55. PubMed ID: 22330686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
